Paper37147404
Parkinson's disease therapy: what lies ahead?
Wolff A and 7 others. J Neural Transm (Vienna), 2023. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Parkinson's disease therapy: what lies ahead? Papers, record 37147404. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37147404
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Parkinson Disease | Major topic |
| Humans | |
| Dopamine | |
| Disease Progression |
Source PubMed
References226
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32651333 | The Choice Between Advanced Therapies for Parkinson's Disease Patients: Why, What, and When? | J Parkinsons Dis | 2020 | https://conductscience.org/library/papers/32651333 | PubMed |
| 2 | 31211166 | α-synuclein RT-QuIC in cerebrospinal fluid of LRRK2-linked Parkinson's disease. | Ann Clin Transl Neurol | 2019 | https://conductscience.org/library/papers/31211166 | PubMed |
| 3 | 26117366 | Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations. | Brain | 2015 | https://conductscience.org/library/papers/26117366 | PubMed |
| 4 | 27548849 | Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression. | Mov Disord | 2016 | https://conductscience.org/library/papers/27548849 | PubMed |
| 5 | 18625222 | Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration. | Exp Neurol | 2008 | https://conductscience.org/library/papers/18625222 | PubMed |
| 6 | 33074190 | Mitochondria and Parkinson's Disease: Clinical, Molecular, and Translational Aspects. | J Parkinsons Dis | 2021 | https://conductscience.org/library/papers/33074190 | PubMed |
| 7 | 30706414 | Ultrasensitive Detection of Aggregated α-Synuclein in Glial Cells, Human Cerebrospinal Fluid, and Brain Tissue Using the RT-QuIC Assay: New High-Throughput Neuroimmune Biomarker Assay for Parkinsonian Disorders. | J Neuroimmune Pharmacol | 2019 | https://conductscience.org/library/papers/30706414 | PubMed |
| 8 | 36402160 | Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial. | Lancet Neurol | 2022 | https://conductscience.org/library/papers/36402160 | PubMed |
| 9 | 33566871 | Patients with scans without evidence of dopaminergic deficit (SWEDD) do not have early Parkinson's disease: Analysis of the PPMI data. | PLoS One | 2021 | https://conductscience.org/library/papers/33566871 | PubMed |
| 10 | 33772855 | Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease. | Ann Neurol | 2021 | https://conductscience.org/library/papers/33772855 | PubMed |
| 11 | 33855335 | Alpha-synuclein seeds in olfactory mucosa of patients with isolated REM sleep behaviour disorder. | Brain | 2021 | https://conductscience.org/library/papers/33855335 | PubMed |
| 12 | 31123700 | Mitochondria function associated genes contribute to Parkinson's Disease risk and later age at onset. | NPJ Parkinsons Dis | 2019 | https://conductscience.org/library/papers/31123700 | PubMed |
| 13 | 32116488 | Motion Biomarkers Showing Maximum Contrast Between Healthy Subjects and Parkinson's Disease Patients Treated With Deep Brain Stimulation of the Subthalamic Nucleus. A Pilot Study. | Front Neurosci | 2019 | https://conductscience.org/library/papers/32116488 | PubMed |
| 14 | 32059811 | Long-term unsupervised mobility assessment in movement disorders. | Lancet Neurol | 2020 | https://conductscience.org/library/papers/32059811 | PubMed |
| 15 | 35350553 | Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based study. | Brain Commun | 2022 | https://conductscience.org/library/papers/35350553 | PubMed |
| 17 | 28233927 | Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials. | Mov Disord | 2017 | https://conductscience.org/library/papers/28233927 | PubMed |
| 18 | 26239690 | Impact of Current Antipsychotic Medications on Comparative Mortality and Adverse Events in People With Parkinson Disease Psychosis. | J Am Med Dir Assoc | 2015 | https://conductscience.org/library/papers/26239690 | PubMed |
| 19 | 34659081 | A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data. | Front Neurol | 2021 | https://conductscience.org/library/papers/34659081 | PubMed |
| 20 | 34289275 | Trial of Pimavanserin in Dementia-Related Psychosis. | N Engl J Med | 2021 | https://conductscience.org/library/papers/34289275 | PubMed |
| 21 | 36036203 | Magnetic Resonance-Guided Focused Ultrasound Thalamotomy May Spare Dopaminergic Therapy in Early-Stage Tremor-Dominant Parkinson's Disease: A Pilot Study. | Mov Disord | 2022 | https://conductscience.org/library/papers/36036203 | PubMed |
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42339433 | Mild cognitive impairment in Parkinson's disease: current view. | Front Cognit | 2024 | https://conductscience.org/library/papers/42339433 | PubMed |
| 42133016 | The future digital outpatient clinic for movement disorders: from technological innovation to ethical and systemic implementation-a position paper. | J Neural Transm (Vienna) | 2026 | https://conductscience.org/library/papers/42133016 | PubMed |
| 41822652 | Potential Synergistic Roles of Ketogenic Diet and Stem Cell Therapy in Parkinson's Disease: A Narrative Review. | Cureus | 2026 | https://conductscience.org/library/papers/41822652 | PubMed |
| 41737007 | Neural correlates of prospective memory in Parkinson's disease: a high-density EEG study. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/41737007 | PubMed |
| 41526401 | Data-driven clinical decision support tool for diagnosing mild cognitive impairment in Parkinson's disease. | NPJ Parkinsons Dis | 2026 | https://conductscience.org/library/papers/41526401 | PubMed |
| 41383702 | Beyond boundaries: Neuroprotective effects of steroids and ecdysteroids in SH-SY5Y cells - A systematic review. | Neuroprotection | 2024 | https://conductscience.org/library/papers/41383702 | PubMed |
| 41030936 | Validation of a Mitochondrial Polygenic Score for Parkinson's Disease. | medRxiv | 2025 | https://conductscience.org/library/papers/41030936 | PubMed |
| 40942672 | InfraRed Thermographic Measurements in Parkinson's Disease Subjects: Preliminary Results. | Sensors (Basel) | 2025 | https://conductscience.org/library/papers/40942672 | PubMed |
| 40529404 | Parkinson's Elevated: improving healthspan. | Front Sports Act Living | 2025 | https://conductscience.org/library/papers/40529404 | PubMed |
| 40336538 | Role and mechanism of molecular hydrogen in the treatment of Parkinson's diseases. | Front Neurosci | 2025 | https://conductscience.org/library/papers/40336538 | PubMed |
| 40289580 | From past to future: Digital approaches to success of clinical drug trials for Parkinson's disease. | J Parkinsons Dis | 2026 | https://conductscience.org/library/papers/40289580 | PubMed |
| 40146621 | IGF2-Reprogrammed Macrophages Ameliorate the Inflammatory Response and Protect Against the Neuroinflammatory Process in Parkinson's Disease Models. | Aging Cell | 2025 | https://conductscience.org/library/papers/40146621 | PubMed |
| 40119187 | Oxytetracycline and its Non-Antibiotic Derivative DOT Protect Midbrain Dopamine Neurons from Iron-Driven Oxidative Damage. | Neurotox Res | 2025 | https://conductscience.org/library/papers/40119187 | PubMed |
| 39770531 | Small Molecules in Parkinson's Disease Therapy: From Dopamine Pathways to New Emerging Targets. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39770531 | PubMed |
| 39717965 | The design and development of LRRK2 inhibitors as novel therapeutics for Parkinson's disease. | Future Med Chem | 2025 | https://conductscience.org/library/papers/39717965 | PubMed |
| 39403917 | The Effectiveness and Safety Analysis of Duloxetine in Treating Comorbid Depression in Parkinson's Disease: A Retrospective Study. | Actas Esp Psiquiatr | 2024 | https://conductscience.org/library/papers/39403917 | PubMed |
| 39199337 | Novel Therapeutic Horizons: SNCA Targeting in Parkinson's Disease. | Biomolecules | 2024 | https://conductscience.org/library/papers/39199337 | PubMed |
| 39125607 | AR71, Histamine H3 Receptor Ligand-In Vitro and In Vivo Evaluation (Anti-Inflammatory Activity, Metabolic Stability, Toxicity, and Analgesic Action). | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39125607 | PubMed |
| 38962146 | Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective? | Front Hum Neurosci | 2024 | https://conductscience.org/library/papers/38962146 | PubMed |
| 38561620 | Single-Cell Nuclear Sequencing Atlas Revealed the Induction of Parkinson's Disease by RELN+ Neuron 3 and the Gene Regulatory Network of MSRA. | Curr Med Chem | 2025 | https://conductscience.org/library/papers/38561620 | PubMed |
Genes28
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37147404
GET https://conductscience.org/api/papers/v1/37147404/references?page=2